Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-06-04 | Reverse | 1:30 |
| 2021-08-09 | Reverse | 1:8 |
IceCure Medical Ltd, founded in 2006 in Caesarea, Israel, develops and commercializes cryoablation devices like the ProSense system for tumor treatment, primarily focusing on freezing tumors such as breast cancer.

IceCure's ProSense® Cryoablation System is a minimally invasive device using liquid nitrogen to freeze and destroy benign and cancerous tumors across multiple organs, offering an alternative to surgery.
| Map | REGION | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
![]() | OtherCountriesMember | $1.29M | $1.51M ▲ | $1.46M ▼ | $1.94M ▲ |
![]() | UNITED STATES | $604K | $751K ▲ | $870K ▲ | $908K ▲ |
![]() | JAPAN | $1.13M | $480K ▼ | $481K ▲ | $282K ▼ |
![]() | INDIA | — | — | $413K | $120K ▼ |
![]() | CHINA | — | $440K | $41K ▼ | $108K ▲ |
![]() | ISRAEL | $30K | $30K | $30K | $24K ▼ |
![]() | THAILAND | $30K | $14K ▼ | — | — |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
ECOR | $10.52 | COMPARE |
TELO | $1.13 | COMPARE |
SRTS | $3.34 | COMPARE |
MDAI | $1.60 | COMPARE |
BDMD | $1.16 | COMPARE |
PETS | $1.76 | COMPARE |
TELA | $0.65 | COMPARE |
CTSO | $0.37 | COMPARE |